A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.

NCT06663943 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Pemphigus Disease
Pemphigus Vulgaris (PV)

Interventions

DRUG: CM313 (SC)
DRUG: Glucocorticoids

Sponsor

Chao Ji